PIVONELLO, ROSARIO
 Distribuzione geografica
Continente #
AS - Asia 12.936
EU - Europa 9.991
NA - Nord America 9.417
SA - Sud America 2.047
AF - Africa 334
OC - Oceania 23
Continente sconosciuto - Info sul continente non disponibili 12
Totale 34.760
Nazione #
US - Stati Uniti d'America 8.927
SG - Singapore 7.027
RU - Federazione Russa 5.224
CN - Cina 2.822
BR - Brasile 1.660
HK - Hong Kong 1.263
IT - Italia 1.246
VN - Vietnam 881
DE - Germania 768
FI - Finlandia 525
NL - Olanda 492
SE - Svezia 381
IE - Irlanda 317
CA - Canada 269
GB - Regno Unito 256
UA - Ucraina 248
IN - India 184
FR - Francia 178
AR - Argentina 149
MX - Messico 144
KR - Corea 110
BD - Bangladesh 100
CI - Costa d'Avorio 100
TR - Turchia 90
PL - Polonia 81
EC - Ecuador 74
ZA - Sudafrica 72
ID - Indonesia 70
ES - Italia 69
IQ - Iraq 62
JP - Giappone 59
CO - Colombia 42
AT - Austria 40
KE - Kenya 30
UZ - Uzbekistan 29
PK - Pakistan 28
LT - Lituania 26
PY - Paraguay 26
VE - Venezuela 26
IL - Israele 25
IR - Iran 24
CL - Cile 23
TN - Tunisia 22
BE - Belgio 21
MA - Marocco 20
SA - Arabia Saudita 20
CZ - Repubblica Ceca 19
AE - Emirati Arabi Uniti 18
EG - Egitto 18
PE - Perù 17
UY - Uruguay 17
JO - Giordania 16
AU - Australia 15
PT - Portogallo 15
LB - Libano 14
CR - Costa Rica 13
DZ - Algeria 13
RO - Romania 11
BO - Bolivia 10
HN - Honduras 10
CH - Svizzera 9
NP - Nepal 9
PH - Filippine 9
AZ - Azerbaigian 8
PA - Panama 8
ET - Etiopia 7
JM - Giamaica 7
LV - Lettonia 7
NI - Nicaragua 7
AF - Afghanistan, Repubblica islamica di 6
DO - Repubblica Dominicana 6
SN - Senegal 6
SY - Repubblica araba siriana 6
AM - Armenia 5
BA - Bosnia-Erzegovina 5
GR - Grecia 5
HU - Ungheria 5
KW - Kuwait 5
OM - Oman 5
SI - Slovenia 5
TH - Thailandia 5
TT - Trinidad e Tobago 5
TW - Taiwan 5
AL - Albania 4
BB - Barbados 4
BG - Bulgaria 4
BW - Botswana 4
BY - Bielorussia 4
CW - ???statistics.table.value.countryCode.CW??? 4
DJ - Gibuti 4
EE - Estonia 4
EU - Europa 4
GM - Gambi 4
MY - Malesia 4
NO - Norvegia 4
PS - Palestinian Territory 4
TL - Timor Orientale 4
XK - ???statistics.table.value.countryCode.XK??? 4
BF - Burkina Faso 3
BH - Bahrain 3
Totale 34.667
Città #
Singapore 3.181
Moscow 1.271
Hong Kong 1.260
Chandler 1.120
Beijing 733
Ashburn 683
Hefei 608
Santa Clara 486
Millbury 472
Amsterdam 419
Naples 339
Ho Chi Minh City 327
Princeton 301
Los Angeles 300
Munich 283
Jacksonville 272
Nanjing 258
Buffalo 202
Wilmington 198
Boston 167
Hanoi 158
Redondo Beach 149
São Paulo 147
Napoli 138
New York 135
Des Moines 123
Ottawa 118
Turku 116
Helsinki 114
Dallas 108
Seoul 105
The Dalles 105
Woodbridge 84
Houston 80
Seattle 80
Lawrence 78
Boardman 77
Nanchang 76
Warsaw 66
Mexico City 62
Montreal 61
Rome 61
Falkenstein 60
Hebei 58
Tokyo 54
Chicago 53
Orem 52
Rio de Janeiro 49
Nuremberg 47
Tianjin 47
Brooklyn 46
Denver 46
Phoenix 45
Frankfurt am Main 43
Shenyang 43
Haiphong 42
London 41
Poplar 41
Toronto 41
Chennai 40
Johannesburg 40
Stockholm 40
Atlanta 39
San Francisco 38
Ann Arbor 36
Changsha 36
Curitiba 35
Da Nang 35
Norwalk 34
Jiaxing 32
Belo Horizonte 31
Kochi 31
Kronberg 31
Ankara 30
Brasília 30
Manchester 30
Biên Hòa 29
Falls Church 28
Shanghai 28
Nairobi 27
Quito 27
Tashkent 27
Porto Alegre 26
San Mateo 26
Dublin 24
Campinas 20
Guayaquil 20
Kunming 20
Milan 20
Ninh Bình 19
Vienna 19
Baghdad 18
Guarulhos 18
Hải Dương 18
Lappeenranta 18
Pune 18
Redwood City 18
Afragola 17
Ardabil 17
Asunción 17
Totale 17.036
Nome #
Spot-light on microbiota in obesity and cancer 178
A New Clinical Model to Estimate the Pre-Test Probability of Cushing’s Syndrome: The Cushing Score 172
Effects of Chrono-Exercise and Chrono-Nutrition on Muscle Health: Understanding the Molecular Mechanisms Activated by Timed Exercise and Consumption of Proteins and Carbohydrates 149
Circulating insulin-like growth factor-I levels are correlated with the atherosclerotic profile in healthy subjects independently of age 148
Sulfur amino acids in Cushing's disease: insight in homocysteine and taurine levels in patients with active and cured disease 145
Exposure to artificial light at night: A common link for obesity and cancer? 144
The 17β-hydroxysteroid dehydrogenase type 3 deficiency: a case report of an 18-year patient and review of the literature. 143
Flavor perception test: evaluation in patients with Kallmann syndrome 143
Short-term effects of growth hormone (GH) treatment or deprivation on cardiovascular risk parameters and intima-media thickness at carotid arteries in patients with severe GH deficiency 142
Neuropsychiatric disorders in Cushing's syndrome. 134
Bone marker and bone density responses to dopamine agonist therapy in hyperprolactinemic males 133
Reduced bone mineral density in glycogen storage disease type III: Evidence for a possible connection between metabolic imbalance and bone homeostasis 133
Selenium supplementation modulates apoptotic processes in thyroid follicular cells 132
The spectrum of cardiac abnormalities in patients with acromegaly: results from a case-control cardiac magnetic resonance study 131
Somatostatin analogs in treatment of non-growth hormone-secreting pituitary adenomas 130
Effects of sex steroids on bone in women with subclinical or overt endogenous hypercortisolism 129
Circulating myomiRNAs as biomarkers in patients with Cushing's syndrome 127
The treatment with growth hormone receptor antagonist in acromegaly: effect on vascular structure and function in patients resistant to somatostatin analogues. 127
The natural history of partial growth hormone deficiency in adults: a prospective study on the cardiovascular risk and atherosclerosis. 126
Effects of long-term combined treatment with somatostatin analogues and pegvisomant on cardiac structure and performance in acromegaly 126
Growth hormone excess with onset in adolescence: clinical appearance and long-term treatment outcome 125
Severe impact of late diagnosis of congenital adrenal hyperplasia on gender identity, sexual orientation and function: case report and review of the literature 123
High prevalence of cardiac valve disease in acromegaly: an observational, analytical, case-control study 123
The role of vitamin D in male fertility: A focus on the testis 122
The Treatment of Cushing's Disease. 121
Partial surgical removal of growth hormone-secreting pituitary tumors enhances the response to somatostatin analogs in acromegaly 121
The effect of FT500 Plus® on ovarian stimulation in PCOS women 121
Air pollution and female fertility: A systematic review of literature 121
The dual targeting of insulin and insulin-like growth factor 1 receptor enhances the mTOR inhibitor-mediated antitumor efficacy in hepatocellular carcinoma 120
Long-term high-dose l-arginine supplementation in patients with vasculogenic erectile dysfunction: a multicentre, double-blind, randomized, placebo-controlled clinical trial 120
Bisphenol A: An emerging threat to female fertility 119
The role of melatonin in the molecular mechanisms underlying metaflammation and infections in obesity: A narrative review 119
Orbital scintigraphy with [111In-diethylenetriamine pentaacetic acid-D-phe1]-octreotide predicts the clinical response to corticosteroid therapy in patients with Graves' ophthalmopathy. 118
New perspectives in the medical treatment of acromegaly 118
Erratum to: The treatment with pasireotide in Cushing’s disease: effects of long–term treatment on tumor mass in the experience of a single center (Endocrine, (2015), 50, (725-740) DOI 10.1007/s12020-015-0557-2) 118
Weekly clodronate treatment prevents bone loss and vertebral fractures in womenwith subclinical Cushing's syndrome. 117
Serum epidermal growth factor predicts cognitive functions in early, drug-naive Parkinson's disease patients. 117
Circadian rhythm of glucocorticoid administration entrains clock genes in immune cells: a DREAM trial ancillary study 117
Adverse events associated with somatostatin analogs in acromegaly. 116
Metabolic alterations and cardiovascular outcomes of cortisol excess 116
The association of fasting insulin concentrations and colonic neoplasms in acromegaly: a colonoscopy-based study in 210 patients 115
Efficacy of 12-month treatment with the GH receptor antagonist pegvisomant in patients with acromegaly resistant to long-term, high-dose somatostatin analog treatment: effect on IGF-I levels, tumor mass, hypertension and glucose tolerance 115
Age changes the diagnostic accuracy of mean profile and nadir growth hormone levels after oral glucose in postoperative patients with acromegaly. 115
Vitamin D reverts resistance to the mTOR inhibitor everolimus in hepatocellular carcinoma through the activation of a miR-375/oncogenes circuit 115
Hypertension in acromegaly and in the normal population: prevalence and determinants 114
A longitudinal study of vasopressin cell antibodies, posterior pituitary function, and magnetic resonance imaging evaluations in subclinical autoimmune central diabetes insipidus 114
Multiple system atrophy is associated with changes in peripheral insulin-like growth factor system. 114
CORTISOL CIRCADIAN RHYTHM AND INSULIN RESISTANCE IN MUSCLE: EFFECT OF DOSING AND TIMING OF HYDROCORTISONE EXPOSURE ON INSULIN SENSITIVITY IN SYNCHRONIZED MUSCLE CELLS 114
Glycogen storage disease type Ia (GSDIa) but not Glycogen storage disease type Ib (GSDIb) is associated to an increased risk of metabolic syndrome: possible role of microsomal glucose 6-phosphate accumulation. 113
CONVENTIONAL AND NUCLEAR MEDICINE IMAGING IN ECTOPIC CUSHING'S SYNDROME: A SYSTEMATIC REVIEW. 113
The environment and male reproduction: The effect of cadmium exposure on reproductive functions and its implication in fertility 113
Macroprolactinoma shrinkage during cabergoline treatment is greater in naive patients than in patients pretreated with other dopamine agonists: a prospective study in 110 patients 113
The Glucocorticoid Analog Dexamethasone Alters the Expression and the Distribution of Dopamine Receptors and Enkephalin within Cortico-subcortical Regions. 113
Very-low-calorie ketogenic diet (VLCKD) in the management of metabolic diseases: systematic review and consensus statement from the Italian Society of Endocrinology (SIE). 113
Impact of Somatostatin Analogs vs. Surgery on glucose metabolism in acromegaly: Results of a 5 years observational, open, prospective study 112
Acromegalic axial arthropathy: a clinical case-control study 112
Correlation between Morphometric parameters and chromatin fragmentation in spermatozoa of Canis familiaris. 112
Effect of gender and gonadal status on the long-term response to somatostatin analogue treatment in acromegaly 111
Cardiovascular risk factors and common carotid artery caliber and stiffness in patients with Cushing's disease during active disease and 1 year after disease remission 111
17 beta hyrossisteroid dehydrogenase type 3 deficiency : a new case of a rare disease with uncommon gene mutation 111
Cushing's syndrome 110
The treatment with pasireotide in Cushing's disease: effects of long-term treatment on tumor mass in the experience of a single center. 110
Fertility in Acromegaly: a single center experience on female patients during active disease and after disease remission 109
Cabergoline plus lanreotide for ectopic Cushing's syndrome. 109
Impairment of bone status in patients with central diabetes insipidus 109
Cushing's syndrome: aftermath of the cure. 109
Cardiovascular alterations in adult GH deficiency 109
Tumor necrosis factor-alpha increases after corticotropin-releasing hormone administration in Cushing's disease. In vivo and in vitro studies. 108
Is diabetes in Cushing's syndrome only a consequence of hypercortisolism? 107
[Chronic kidney disease: fertility and sexuality] 107
Acromegaly is associated with increased cancer risk: A survey in Italy 107
Acromegaly and the cardiovascular system 106
Octreotide-LAR vs lanreotide-SR as first-line therapy for acromegaly: A retrospective, comparative, head-to-head study 106
Pathophysiology of diabetes mellitus in Cushing's syndrome. 106
Shedding new light on female fertility: The role of vitamin D 106
Vitamin D Reverts the Exosome-Mediated Transfer of Cancer Resistance to the mTOR Inhibitor Everolimus in Hepatocellular Carcinoma 106
1,25‑Dihydroxyvitamin D3 mitigates the adipogenesis induced by bisphenol A in 3T3-L1 and hAMSC through miR-27-3p regulation 105
First-line octreotide-LAR therapy induces tumour shrinkage and controls hormone excess in patients with acromegaly: results from an open, prospective, multicentre trial. 105
Cardiovascular consequences of early-onset growth hormone excess 105
The kidney in acromegaly: renal structure and function in patients with acromegaly during active disease and 1 year after disease remission. 105
The role of somatostatin analogs in the management of hepatocellular carcinoma 104
Effects of the single and combined treatment with dopamine agonist, somatostatin analog and mTOR inhibitors in a human lung carcinoid cell line: an in vitro study 104
Antipituitary antibodies in idiopathic hyperprolactinemic patients 103
The pituitary uptake of (111)In-DTPA-D-Phe1-octreotide in the normal pituitary and in pituitary adenomas 103
Dopamine receptor expression and function in clinically nonfunctioning pituitary tumors: comparison with the effectiveness of cabergoline treatment 103
Cardiac effect of thyrotoxicosis in acromegaly 103
Increased IGF-I : IGFBP-3 ratio in patients with hepatocellular carcinoma 103
Complete disappearance of a GH-secreting pituitary macroadenoma in a patient with acromegaly: effect of treatment with lanreotide Autogel and consequence of treatment withdrawal. 103
Effect of Cabergoline on Metabolism in Prolactinomas. 103
Effect of Chronic Cabergoline Treatment and Testosterone Replacement on Metabolism in Male Patients with Prolactinomas 103
Effect of combined treatment with a pan-PI3K inhibitor or an isoform-specific PI3K inhibitor and everolimus on cell proliferation in GH-secreting pituitary tumour in an experimental setting 103
Evaluation of morphometric parameters and chromatin integrity in the sperm of stallion food supplemented with Maca. 103
Imbalanced cortisol concentrations in glycogen storage disease type I: Evidence for a possible link between endocrine regulation and metabolic derangement 103
The Interplay Between Prolactin and Reproductive System: Focus on Uterine Pathophysiology 103
Effect of growth hormone (GH) and insulin-like growth factor I on prostate diseases: an ultrasonographic and endocrine study in acromegaly, GH deficiency, and healthy subjects 102
Insulin-like growth factor-1 deficiency determines increased intima-media thickness at common carotid arteries in adult patients with growth hormone deficiency 102
The GH-IGF system in amyotrophic lateral sclerosis: correlations between pituitary GH secretion capacity, insulin-like growth factors and clinical features. 102
Cardiovascular disease in Cushing's syndrome: heart versus vasculature. 102
The role of dopamine pathway on human sperm: in vitro effect of dopamine receptor agonists and antagonists on sperm motility, kinetics and viability 102
Approach to the Patient with Prolactinoma 101
Totale 11.646
Categoria #
all - tutte 121.378
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 121.378


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021492 0 0 0 0 0 156 46 8 83 32 134 33
2021/20222.206 37 7 10 25 54 213 29 61 370 120 374 906
2022/20232.703 408 226 74 213 328 261 27 230 374 414 112 36
2023/20241.763 86 271 239 141 80 114 49 190 26 36 312 219
2024/202511.778 631 753 99 95 252 584 1.324 759 852 1.050 4.290 1.089
2025/202613.579 2.574 1.852 2.423 2.097 4.005 628 0 0 0 0 0 0
Totale 35.394